119-HR-1336 Veteran or Active Service Member Impact Perspective

Summary of my opinion of H.R. 1336

Duty and honor demand we offer real, effective care—never symbolic gestures. This bill’s heart is in the right place, but promises must be kept with evidence and resources. As written, the HBOT pilot leans ahead of the science, relies on donations, and helps veterans in only two VISNs; that invites inequity and disappointment. Rigorous trials to date have not shown HBOT outperforming well‑designed sham treatments for persistent post‑concussive symptoms or PTSD, and UHMS still lists TBI/PTSD as investigational indications; FDA has not cleared HBOT devices for these uses. [1]PubMed — JAMA Internal Medicine: Effects of hyperbaric oxygen vs sham for persi…[2]UHMS — Undersea & Hyperbaric Medical Society — HBO Indications (TBI/PTSD invest…[3]U.S. Food & Drug Administration — FDA Consumer Update — Hyperbaric Oxygen Thera…

• What I welcome: accreditation requirements; FDA‑cleared or IDE devices; and a GAO update to keep Congress honest on the evidence. [3]U.S. Food & Drug Administration — FDA Consumer Update — Hyperbaric Oxygen Thera…[4]U.S. Government Accountability Office — GAO-16-154 — Research on Hyperbaric Oxy…
• What I cannot accept: donation‑only funding (no guaranteed access), a two‑VISN cap (zip‑code lotteries), and an unrelated Section 4 provision that extends pension limits on institutionalized veterans to 2034. [5]Legal Information Institute — 38 U.S.C. § 5503 — Hospitalized veterans and esta…

Specific impacts and my judgment

I assess impact through the lens of VA services, mental health outcomes, and whether the promise will be delivered fairly to all who served.

• Economic (veterans/households): Donation‑only funding means slots will track philanthropy, not need. Veterans outside the two VISNs could face travel costs or waitlists; if donations ebb, mid‑course cancellations betray trust.
• Economic (VA system): Minimal near‑term appropriations, but operational burden (referrals, safety oversight, GAO data calls) is real. If the pilot uses community providers, VA still must ensure accredited facilities and device safety. [3]U.S. Food & Drug Administration — FDA Consumer Update — Hyperbaric Oxygen Thera…
• Social (access and equity): Two‑VISN limit creates winners and losers by geography and may advantage urban vets near chambers. It may also divert attention from proven, available PTSD treatments (CPT, PE, EMDR) that VA already offers nationwide. [6]U.S. Department of Veterans Affairs — PTSD treatment services at VA (evidence‑b…
• Clinical effectiveness: Best‑designed VA/DoD trials show HBOT did not beat sham for persistent post‑concussive symptoms; UHMS continues to regard TBI/PTSD as investigational. [1]PubMed — JAMA Internal Medicine: Effects of hyperbaric oxygen vs sham for persi…[2]UHMS — Undersea & Hyperbaric Medical Society — HBO Indications (TBI/PTSD invest…
• Safety: HBOT is generally safe in accredited settings, but risks include ear/sinus barotrauma, reversible vision changes, rare lung collapse or seizures, and elevated fire risk—necessitating strict accreditation and protocols. FDA reiterated safe‑use warnings in 2025. [3]U.S. Food & Drug Administration — FDA Consumer Update — Hyperbaric Oxygen Thera…[7]U.S. Food & Drug Administration — FDA 2025 letter to health care providers — Sa…
• Mental‑health urgency: Veterans die by suicide at roughly 17.6 per day (2022). Innovation is welcome, but it must complement—not replace—evidence‑based care and be offered without financial hurdles. [8]U.S. Department of Veterans Affairs — VA News: 2024 National Veteran Suicide Pr…
• Environmental: Negligible system‑wide footprint beyond oxygen and electricity demand; main risk surface is safety (fire) rather than emissions. [7]U.S. Food & Drug Administration — FDA 2025 letter to health care providers — Sa…
• Long‑ vs. short‑term effects: Some trials report short‑term symptom gains that fade by 6–12 months—underscoring the need for a rigorously powered, sham‑controlled design and long follow‑up in any VA pilot. [9]PubMed — Hyperbaric oxygen for post-concussive symptoms in U.S. military servic…
• Unintended consequences: Donation‑driven supply can drive veterans toward non‑accredited clinics if access is scarce; FDA cautions against unproven claims and non‑accredited settings—precisely why the bill’s accreditation guardrails matter but also why access must be planned, not left to chance. [3]U.S. Food & Drug Administration — FDA Consumer Update — Hyperbaric Oxygen Thera…

What amendments would earn my support

1. Appropriate funds (do not rely on donations) and forbid any veteran out‑of‑pocket costs, with travel/lodging covered when care is not local.
2. Expand beyond two VISNs or create a national referral pathway (with tele‑screening) so access follows need, not geography.
3. Require a VA/DoD–designed, multi‑site, sham‑controlled RCT with preregistered endpoints, independent DSMB, and full data transparency; integrate with evidence‑based PTSD/TBI care pathways. [4]U.S. Government Accountability Office — GAO-16-154 — Research on Hyperbaric Oxy…
4. Codify safety: accredited facilities only; adherence to FDA safe‑use guidance; mandatory adverse‑event reporting. [7]U.S. Food & Drug Administration — FDA 2025 letter to health care providers — Sa…
5. Time‑box the pilot to 3 years but condition continuation on meeting enrollment, safety, and reporting milestones; publish results for veterans and families in plain language.
6. Remove Section 4’s pension‑limit extension; do not trade away benefits to fund an unfunded pilot. [5]Legal Information Institute — 38 U.S.C. § 5503 — Hospitalized veterans and esta…

Key metrics I’m watching

Sources for context include VA’s 2024 suicide report (17.6/day) and HBOT trial designs commonly using ~40 sessions. [8]U.S. Department of Veterans Affairs — VA News: 2024 National Veteran Suicide Pr…[1]PubMed — JAMA Internal Medicine: Effects of hyperbaric oxygen vs sham for persi…

Overall stance

I view H.R. 1336 unfavorably as written. It honors veterans in spirit but risks unequal access, inflated expectations, and a hidden benefit cut. Amend it to fund access, demand first‑rate science, and protect pensions, and I will support a tightly run pilot—because in this community, promises kept matter most.

If Congress proceeds without changes, VA must ensure veterans are fully informed: HBOT for TBI/PTSD remains investigational, not FDA‑cleared; benefits are uncertain versus sham; and safety requires accredited settings. [2]UHMS — Undersea & Hyperbaric Medical Society — HBO Indications (TBI/PTSD invest…[3]U.S. Food & Drug Administration — FDA Consumer Update — Hyperbaric Oxygen Thera…